AAAAAA

   
Results: 1-18 |
Results: 18

Authors: YEW WW CHAU CH
Citation: Ww. Yew et Ch. Chau, FUTURE-DIRECTIONS IN THE DEVELOPMENT OF NEW ANTITUBERCULAR DRUGS - WHERE DO WE GO FROM HERE, Drugs & aging, 10(6), 1997, pp. 405-410

Authors: YEW WW AU KF LEE J CHAU CH
Citation: Ww. Yew et al., LEVOFLOXACIN IN THE TREATMENT OF DRUG-RESISTANT TUBERCULOSIS, The international journal of tuberculosis and lung disease, 1(1), 1997, pp. 89-89

Authors: CHAU CH YEW WW WONG PC LEE J WONG CF
Citation: Ch. Chau et al., USEFULNESS OF COLLECTING ROUTINE CYTOLOGIC SPECIMENS DURING FIBEROPTIC BRONCHOSCOPY FOR ENDOSCOPICALLY VISIBLE AND NONVISIBLE LUNG-CARCINOMA, Chest, 111(2), 1997, pp. 522-523

Authors: YEW WW CHAU CH WEN KH
Citation: Ww. Yew et al., PSEUDOMEMBRANOUS COLITIS IN A PATIENT TREATED WITH OFLOXACIN FOR TUBERCULOSIS, Tubercle and lung disease, 77(5), 1996, pp. 484-484

Authors: YEW WW CHAU CH LEUNG S
Citation: Ww. Yew et al., ANTITUBERCULOSIS DRUGS AND LIVER TOXICITY, The European respiratory journal, 9(2), 1996, pp. 389-390

Authors: YEW WW LEE J WONG PC WONG CF CHAU CH
Citation: Ww. Yew et al., LOW-DOSE METHOTREXATE IN THE MANAGEMENT OF CHINESE PATIENTS WITH STEROID-DEPENDENT ASTHMA, Drugs under experimental and clinical research, 22(6), 1996, pp. 317-321

Authors: YEW WW WONG PC WONG CF LEE J CHAU CH
Citation: Ww. Yew et al., ORAL FLUCONAZOLE IN THE TREATMENT OF PULMONARY CRYPTOCOCCOSIS IN NON-AIDS PATIENTS, Drugs under experimental and clinical research, 22(1), 1996, pp. 25-28

Authors: SHUM DKY CHAU CH
Citation: Dky. Shum et Ch. Chau, CHANGES IN GLYCOSAMINOGLYCANS DURING REGENERATION OF POST-CRUSH SCIATIC-NERVES OF ADULT GUINEA-PIGS, Journal of neuroscience research, 46(4), 1996, pp. 465-476

Authors: YEW WW CHAU CH LEE J LEUNG CW
Citation: Ww. Yew et al., CLARITHROMYCIN-INDUCED HEPATOTOXICITY - REPLY, Clinical infectious diseases, 20(4), 1995, pp. 1074-1074

Authors: YEW WW CHAU CH WONG PC CHOI HY
Citation: Ww. Yew et al., CIPROFLAXIN-INDUCED RENAL DYSFUNCTION IN PATIENTS WITH MYCOBACTERIAL LUNG INFECTIONS, Tubercle and lung disease, 76(2), 1995, pp. 173-175

Authors: YEW WW WONG CF LEE J WONG PC CHAU CH
Citation: Ww. Yew et al., DO BETA-LACTAM-BETA-LACTAMASE INHIBITOR COMBINATIONS HAVE A PLACE IN THE TREATMENT OF MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS, Tubercle and lung disease, 76(1), 1995, pp. 90-92

Authors: YEW WW CHAU CH
Citation: Ww. Yew et Ch. Chau, DRUG-RESISTANT TUBERCULOSIS IN THE 1990S, The European respiratory journal, 8(7), 1995, pp. 1184-1192

Authors: YEW WW CHAU CH WONG PC LEE J WONG CF CHEUNG SW CHAN CY CHENG AFB
Citation: Ww. Yew et al., CIPROFLOXACIN IN THE MANAGEMENT OF PULMONARY TUBERCULOSIS IN THE FACEOF HEPATIC-DYSFUNCTION, Drugs under experimental and clinical research, 21(2), 1995, pp. 79-83

Authors: YEW WW WONG PC WONG CF CHAU CH
Citation: Ww. Yew et al., USE OF IMIPENEM IN THE TREATMENT OF THORACIC ACTINOMYCOSIS, Clinical infectious diseases, 19(5), 1994, pp. 983-984

Authors: YEW WW CHAU CH TSE LS
Citation: Ww. Yew et al., DOES HOSPITALIZING PATIENTS WITH TUBERCULOSIS ENSURE COMPLIANCE WITH DRUG REGIMENS, Clinical infectious diseases, 19(3), 1994, pp. 554-555

Authors: YEW WW CHAU CH LEE J LEUNG CW
Citation: Ww. Yew et al., CHOLESTATIC HEPATITIS IN A PATIENT WHO RECEIVED CLARITHROMYCIN THERAPY FOR A MYCOBACTERIUM-CHELONAE LUNG INFECTION, Clinical infectious diseases, 18(6), 1994, pp. 1025-1026

Authors: YEW WW WONG CF WONG PC LEE J CHAU CH
Citation: Ww. Yew et al., ADVERSE NEUROLOGICAL REACTIONS IN PATIENTS WITH MULTIDRUG-RESISTANT PULMONARY TUBERCULOSIS AFTER COADMINISTRATION OF CYCLOSERINE AND OFLOXACIN, Clinical infectious diseases, 17(2), 1993, pp. 288-289

Authors: DICKENS P PITTALUGA S CHAU CH
Citation: P. Dickens et al., SUDDEN-DEATH PRESENTING AS MASSIVE HEMOPTYSIS DUE TO RUPTURED INTRAPULMONARY AORTIC-ANEURYSM, Forensic science international, 60(1-2), 1993, pp. 121-125
Risultati: 1-18 |